nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—PGR—Betamethasone—psoriatic arthritis	0.14	0.153	CbGbCtD
Mifepristone—NR3C1—Methylprednisolone—psoriatic arthritis	0.11	0.12	CbGbCtD
Mifepristone—NR3C1—Triamcinolone—psoriatic arthritis	0.0836	0.0911	CbGbCtD
Mifepristone—PGR—Dexamethasone—psoriatic arthritis	0.0817	0.089	CbGbCtD
Mifepristone—NR3C1—Betamethasone—psoriatic arthritis	0.0717	0.0782	CbGbCtD
Mifepristone—NR3C1—Prednisolone—psoriatic arthritis	0.0707	0.0771	CbGbCtD
Mifepristone—NR3C1—Prednisone—psoriatic arthritis	0.0668	0.0729	CbGbCtD
Mifepristone—NR3C1—Dexamethasone—psoriatic arthritis	0.0417	0.0455	CbGbCtD
Mifepristone—ABCC1—Methotrexate—psoriatic arthritis	0.0323	0.0353	CbGbCtD
Mifepristone—ABCB1—Methylprednisolone—psoriatic arthritis	0.0257	0.028	CbGbCtD
Mifepristone—CYP3A7—Dexamethasone—psoriatic arthritis	0.0199	0.0217	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0199	0.0217	CbGbCtD
Mifepristone—ABCB1—Betamethasone—psoriatic arthritis	0.0167	0.0182	CbGbCtD
Mifepristone—ABCB1—Prednisolone—psoriatic arthritis	0.0165	0.018	CbGbCtD
Mifepristone—ABCB1—Prednisone—psoriatic arthritis	0.0156	0.017	CbGbCtD
Mifepristone—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0154	0.0168	CbGbCtD
Mifepristone—CYP3A5—Dexamethasone—psoriatic arthritis	0.0149	0.0163	CbGbCtD
Mifepristone—CYP3A4—Triamcinolone—psoriatic arthritis	0.0117	0.0127	CbGbCtD
Mifepristone—CYP3A4—Betamethasone—psoriatic arthritis	0.01	0.0109	CbGbCtD
Mifepristone—CYP3A4—Prednisolone—psoriatic arthritis	0.00987	0.0108	CbGbCtD
Mifepristone—ABCB1—Dexamethasone—psoriatic arthritis	0.00971	0.0106	CbGbCtD
Mifepristone—CYP3A4—Prednisone—psoriatic arthritis	0.00932	0.0102	CbGbCtD
Mifepristone—CYP2D6—Dexamethasone—psoriatic arthritis	0.00915	0.00998	CbGbCtD
Mifepristone—ABCB1—Methotrexate—psoriatic arthritis	0.00781	0.00851	CbGbCtD
Mifepristone—CYP3A4—Dexamethasone—psoriatic arthritis	0.00582	0.00635	CbGbCtD
Mifepristone—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.00043	0.00518	CcSEcCtD
Mifepristone—Hypokalaemia—Dexamethasone—psoriatic arthritis	0.000403	0.00486	CcSEcCtD
Mifepristone—Hypokalaemia—Betamethasone—psoriatic arthritis	0.000403	0.00486	CcSEcCtD
Mifepristone—Muscular weakness—Betamethasone—psoriatic arthritis	0.000391	0.00471	CcSEcCtD
Mifepristone—Muscular weakness—Dexamethasone—psoriatic arthritis	0.000391	0.00471	CcSEcCtD
Mifepristone—Infestation—Methylprednisolone—psoriatic arthritis	0.000375	0.00453	CcSEcCtD
Mifepristone—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.000375	0.00453	CcSEcCtD
Mifepristone—Haemoglobin—Prednisolone—psoriatic arthritis	0.000369	0.00445	CcSEcCtD
Mifepristone—Haemorrhage—Prednisolone—psoriatic arthritis	0.000367	0.00443	CcSEcCtD
Mifepristone—Hypokalaemia—Prednisone—psoriatic arthritis	0.000351	0.00423	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.000342	0.00412	CcSEcCtD
Mifepristone—Muscular weakness—Prednisone—psoriatic arthritis	0.00034	0.0041	CcSEcCtD
Mifepristone—Haemoglobin—Triamcinolone—psoriatic arthritis	0.000339	0.00409	CcSEcCtD
Mifepristone—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.000339	0.00408	CcSEcCtD
Mifepristone—Haemorrhage—Triamcinolone—psoriatic arthritis	0.000338	0.00407	CcSEcCtD
Mifepristone—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.000337	0.00406	CcSEcCtD
Mifepristone—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.000331	0.00399	CcSEcCtD
Mifepristone—Haemoglobin—Dexamethasone—psoriatic arthritis	0.000308	0.00371	CcSEcCtD
Mifepristone—Haemoglobin—Betamethasone—psoriatic arthritis	0.000308	0.00371	CcSEcCtD
Mifepristone—Haemorrhage—Betamethasone—psoriatic arthritis	0.000306	0.0037	CcSEcCtD
Mifepristone—Haemorrhage—Dexamethasone—psoriatic arthritis	0.000306	0.0037	CcSEcCtD
Mifepristone—Angiopathy—Methylprednisolone—psoriatic arthritis	0.000306	0.00369	CcSEcCtD
Mifepristone—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.000304	0.00366	CcSEcCtD
Mifepristone—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000297	0.00358	CcSEcCtD
Mifepristone—Mental disorder—Methylprednisolone—psoriatic arthritis	0.000295	0.00356	CcSEcCtD
Mifepristone—Malnutrition—Methylprednisolone—psoriatic arthritis	0.000293	0.00354	CcSEcCtD
Mifepristone—Angioedema—Prednisolone—psoriatic arthritis	0.000292	0.00352	CcSEcCtD
Mifepristone—Breast disorder—Methotrexate—psoriatic arthritis	0.000291	0.00351	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.00029	0.0035	CcSEcCtD
Mifepristone—Malaise—Prednisolone—psoriatic arthritis	0.000288	0.00348	CcSEcCtD
Mifepristone—Back pain—Triamcinolone—psoriatic arthritis	0.000284	0.00343	CcSEcCtD
Mifepristone—Angiopathy—Dexamethasone—psoriatic arthritis	0.000278	0.00335	CcSEcCtD
Mifepristone—Angiopathy—Betamethasone—psoriatic arthritis	0.000278	0.00335	CcSEcCtD
Mifepristone—Hypertension—Prednisolone—psoriatic arthritis	0.000276	0.00333	CcSEcCtD
Mifepristone—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000273	0.00329	CcSEcCtD
Mifepristone—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000272	0.00328	CcSEcCtD
Mifepristone—Discomfort—Prednisolone—psoriatic arthritis	0.000269	0.00324	CcSEcCtD
Mifepristone—Angioedema—Triamcinolone—psoriatic arthritis	0.000269	0.00324	CcSEcCtD
Mifepristone—Haemoglobin—Prednisone—psoriatic arthritis	0.000268	0.00323	CcSEcCtD
Mifepristone—Angioedema—Methylprednisolone—psoriatic arthritis	0.000268	0.00323	CcSEcCtD
Mifepristone—Haemorrhage—Prednisone—psoriatic arthritis	0.000267	0.00322	CcSEcCtD
Mifepristone—Malaise—Triamcinolone—psoriatic arthritis	0.000265	0.0032	CcSEcCtD
Mifepristone—Malaise—Methylprednisolone—psoriatic arthritis	0.000264	0.00319	CcSEcCtD
Mifepristone—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000262	0.00316	CcSEcCtD
Mifepristone—Oedema—Prednisolone—psoriatic arthritis	0.000261	0.00315	CcSEcCtD
Mifepristone—Hypertension—Triamcinolone—psoriatic arthritis	0.000254	0.00306	CcSEcCtD
Mifepristone—Hypertension—Methylprednisolone—psoriatic arthritis	0.000253	0.00305	CcSEcCtD
Mifepristone—Myalgia—Triamcinolone—psoriatic arthritis	0.00025	0.00302	CcSEcCtD
Mifepristone—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00025	0.00301	CcSEcCtD
Mifepristone—Myalgia—Methylprednisolone—psoriatic arthritis	0.00025	0.00301	CcSEcCtD
Mifepristone—Anxiety—Methylprednisolone—psoriatic arthritis	0.000249	0.003	CcSEcCtD
Mifepristone—Infestation NOS—Methotrexate—psoriatic arthritis	0.000248	0.003	CcSEcCtD
Mifepristone—Infestation—Methotrexate—psoriatic arthritis	0.000248	0.003	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000248	0.00299	CcSEcCtD
Mifepristone—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000247	0.00298	CcSEcCtD
Mifepristone—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000247	0.00298	CcSEcCtD
Mifepristone—Discomfort—Triamcinolone—psoriatic arthritis	0.000247	0.00298	CcSEcCtD
Mifepristone—Discomfort—Methylprednisolone—psoriatic arthritis	0.000247	0.00298	CcSEcCtD
Mifepristone—Dry mouth—Triamcinolone—psoriatic arthritis	0.000245	0.00295	CcSEcCtD
Mifepristone—Angioedema—Betamethasone—psoriatic arthritis	0.000244	0.00294	CcSEcCtD
Mifepristone—Angioedema—Dexamethasone—psoriatic arthritis	0.000244	0.00294	CcSEcCtD
Mifepristone—Angiopathy—Prednisone—psoriatic arthritis	0.000242	0.00292	CcSEcCtD
Mifepristone—Malaise—Dexamethasone—psoriatic arthritis	0.000241	0.0029	CcSEcCtD
Mifepristone—Malaise—Betamethasone—psoriatic arthritis	0.000241	0.0029	CcSEcCtD
Mifepristone—Oedema—Triamcinolone—psoriatic arthritis	0.00024	0.00289	CcSEcCtD
Mifepristone—Infection—Triamcinolone—psoriatic arthritis	0.000238	0.00287	CcSEcCtD
Mifepristone—Infection—Methylprednisolone—psoriatic arthritis	0.000238	0.00287	CcSEcCtD
Mifepristone—Insomnia—Prednisolone—psoriatic arthritis	0.000236	0.00285	CcSEcCtD
Mifepristone—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000235	0.00283	CcSEcCtD
Mifepristone—Mental disorder—Prednisone—psoriatic arthritis	0.000234	0.00282	CcSEcCtD
Mifepristone—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000233	0.0028	CcSEcCtD
Mifepristone—Malnutrition—Prednisone—psoriatic arthritis	0.000232	0.0028	CcSEcCtD
Mifepristone—Hypertension—Betamethasone—psoriatic arthritis	0.00023	0.00278	CcSEcCtD
Mifepristone—Hypertension—Dexamethasone—psoriatic arthritis	0.00023	0.00278	CcSEcCtD
Mifepristone—Myalgia—Betamethasone—psoriatic arthritis	0.000227	0.00274	CcSEcCtD
Mifepristone—Myalgia—Dexamethasone—psoriatic arthritis	0.000227	0.00274	CcSEcCtD
Mifepristone—Anxiety—Dexamethasone—psoriatic arthritis	0.000226	0.00273	CcSEcCtD
Mifepristone—Anxiety—Betamethasone—psoriatic arthritis	0.000226	0.00273	CcSEcCtD
Mifepristone—Discomfort—Betamethasone—psoriatic arthritis	0.000224	0.00271	CcSEcCtD
Mifepristone—Discomfort—Dexamethasone—psoriatic arthritis	0.000224	0.00271	CcSEcCtD
Mifepristone—Haemoglobin—Methotrexate—psoriatic arthritis	0.000224	0.0027	CcSEcCtD
Mifepristone—Hypotension—Methylprednisolone—psoriatic arthritis	0.000224	0.0027	CcSEcCtD
Mifepristone—Pain—Prednisolone—psoriatic arthritis	0.000223	0.00269	CcSEcCtD
Mifepristone—Haemorrhage—Methotrexate—psoriatic arthritis	0.000223	0.00269	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000219	0.00264	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000218	0.00263	CcSEcCtD
Mifepristone—Oedema—Dexamethasone—psoriatic arthritis	0.000218	0.00263	CcSEcCtD
Mifepristone—Oedema—Betamethasone—psoriatic arthritis	0.000218	0.00263	CcSEcCtD
Mifepristone—Insomnia—Triamcinolone—psoriatic arthritis	0.000217	0.00262	CcSEcCtD
Mifepristone—Insomnia—Methylprednisolone—psoriatic arthritis	0.000216	0.00261	CcSEcCtD
Mifepristone—Infection—Betamethasone—psoriatic arthritis	0.000216	0.00261	CcSEcCtD
Mifepristone—Infection—Dexamethasone—psoriatic arthritis	0.000216	0.00261	CcSEcCtD
Mifepristone—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000216	0.0026	CcSEcCtD
Mifepristone—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000215	0.00259	CcSEcCtD
Mifepristone—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000214	0.00258	CcSEcCtD
Mifepristone—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000213	0.00257	CcSEcCtD
Mifepristone—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000213	0.00257	CcSEcCtD
Mifepristone—Angioedema—Prednisone—psoriatic arthritis	0.000212	0.00256	CcSEcCtD
Mifepristone—Malaise—Prednisone—psoriatic arthritis	0.000209	0.00253	CcSEcCtD
Mifepristone—Anorexia—Dexamethasone—psoriatic arthritis	0.000207	0.0025	CcSEcCtD
Mifepristone—Anorexia—Betamethasone—psoriatic arthritis	0.000207	0.0025	CcSEcCtD
Mifepristone—Urticaria—Prednisolone—psoriatic arthritis	0.000207	0.0025	CcSEcCtD
Mifepristone—Fatigue—Triamcinolone—psoriatic arthritis	0.000207	0.00249	CcSEcCtD
Mifepristone—Fatigue—Methylprednisolone—psoriatic arthritis	0.000206	0.00249	CcSEcCtD
Mifepristone—Pain—Triamcinolone—psoriatic arthritis	0.000205	0.00247	CcSEcCtD
Mifepristone—Hypotension—Betamethasone—psoriatic arthritis	0.000203	0.00245	CcSEcCtD
Mifepristone—Hypotension—Dexamethasone—psoriatic arthritis	0.000203	0.00245	CcSEcCtD
Mifepristone—Angiopathy—Methotrexate—psoriatic arthritis	0.000202	0.00244	CcSEcCtD
Mifepristone—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000201	0.00242	CcSEcCtD
Mifepristone—Hypertension—Prednisone—psoriatic arthritis	0.000201	0.00242	CcSEcCtD
Mifepristone—Chills—Methotrexate—psoriatic arthritis	0.0002	0.00241	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000198	0.00239	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000198	0.00239	CcSEcCtD
Mifepristone—Myalgia—Prednisone—psoriatic arthritis	0.000198	0.00238	CcSEcCtD
Mifepristone—Arthralgia—Prednisone—psoriatic arthritis	0.000198	0.00238	CcSEcCtD
Mifepristone—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000198	0.00238	CcSEcCtD
Mifepristone—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000197	0.00238	CcSEcCtD
Mifepristone—Anxiety—Prednisone—psoriatic arthritis	0.000197	0.00238	CcSEcCtD
Mifepristone—Insomnia—Dexamethasone—psoriatic arthritis	0.000197	0.00237	CcSEcCtD
Mifepristone—Insomnia—Betamethasone—psoriatic arthritis	0.000197	0.00237	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000196	0.00237	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000196	0.00236	CcSEcCtD
Mifepristone—Discomfort—Prednisone—psoriatic arthritis	0.000195	0.00236	CcSEcCtD
Mifepristone—Mental disorder—Methotrexate—psoriatic arthritis	0.000195	0.00236	CcSEcCtD
Mifepristone—Malnutrition—Methotrexate—psoriatic arthritis	0.000194	0.00234	CcSEcCtD
Mifepristone—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000192	0.00232	CcSEcCtD
Mifepristone—Urticaria—Triamcinolone—psoriatic arthritis	0.000191	0.0023	CcSEcCtD
Mifepristone—Urticaria—Methylprednisolone—psoriatic arthritis	0.00019	0.00229	CcSEcCtD
Mifepristone—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00019	0.00229	CcSEcCtD
Mifepristone—Oedema—Prednisone—psoriatic arthritis	0.00019	0.00229	CcSEcCtD
Mifepristone—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000189	0.00228	CcSEcCtD
Mifepristone—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000189	0.00228	CcSEcCtD
Mifepristone—Decreased appetite—Betamethasone—psoriatic arthritis	0.000189	0.00228	CcSEcCtD
Mifepristone—Infection—Prednisone—psoriatic arthritis	0.000188	0.00227	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000188	0.00227	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000188	0.00227	CcSEcCtD
Mifepristone—Back pain—Methotrexate—psoriatic arthritis	0.000188	0.00226	CcSEcCtD
Mifepristone—Fatigue—Dexamethasone—psoriatic arthritis	0.000188	0.00226	CcSEcCtD
Mifepristone—Fatigue—Betamethasone—psoriatic arthritis	0.000188	0.00226	CcSEcCtD
Mifepristone—Pain—Betamethasone—psoriatic arthritis	0.000186	0.00225	CcSEcCtD
Mifepristone—Pain—Dexamethasone—psoriatic arthritis	0.000186	0.00225	CcSEcCtD
Mifepristone—Nervous system disorder—Prednisone—psoriatic arthritis	0.000186	0.00224	CcSEcCtD
Mifepristone—Skin disorder—Prednisone—psoriatic arthritis	0.000184	0.00222	CcSEcCtD
Mifepristone—Anorexia—Prednisone—psoriatic arthritis	0.000181	0.00218	CcSEcCtD
Mifepristone—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00018	0.00217	CcSEcCtD
Mifepristone—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000179	0.00216	CcSEcCtD
Mifepristone—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000179	0.00216	CcSEcCtD
Mifepristone—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000178	0.00215	CcSEcCtD
Mifepristone—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000178	0.00215	CcSEcCtD
Mifepristone—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000177	0.00213	CcSEcCtD
Mifepristone—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000176	0.00213	CcSEcCtD
Mifepristone—Malaise—Methotrexate—psoriatic arthritis	0.000175	0.00211	CcSEcCtD
Mifepristone—Urticaria—Dexamethasone—psoriatic arthritis	0.000173	0.00209	CcSEcCtD
Mifepristone—Urticaria—Betamethasone—psoriatic arthritis	0.000173	0.00209	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000173	0.00208	CcSEcCtD
Mifepristone—Dizziness—Prednisolone—psoriatic arthritis	0.000173	0.00208	CcSEcCtD
Mifepristone—Asthenia—Triamcinolone—psoriatic arthritis	0.000172	0.00208	CcSEcCtD
Mifepristone—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000172	0.00208	CcSEcCtD
Mifepristone—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000172	0.00208	CcSEcCtD
Mifepristone—Abdominal pain—Betamethasone—psoriatic arthritis	0.000172	0.00208	CcSEcCtD
Mifepristone—Body temperature increased—Betamethasone—psoriatic arthritis	0.000172	0.00208	CcSEcCtD
Mifepristone—Asthenia—Methylprednisolone—psoriatic arthritis	0.000172	0.00207	CcSEcCtD
Mifepristone—Insomnia—Prednisone—psoriatic arthritis	0.000171	0.00207	CcSEcCtD
Mifepristone—Pruritus—Triamcinolone—psoriatic arthritis	0.00017	0.00205	CcSEcCtD
Mifepristone—Pruritus—Methylprednisolone—psoriatic arthritis	0.000169	0.00204	CcSEcCtD
Mifepristone—Myalgia—Methotrexate—psoriatic arthritis	0.000165	0.00199	CcSEcCtD
Mifepristone—Arthralgia—Methotrexate—psoriatic arthritis	0.000165	0.00199	CcSEcCtD
Mifepristone—Decreased appetite—Prednisone—psoriatic arthritis	0.000165	0.00199	CcSEcCtD
Mifepristone—Rash—Prednisolone—psoriatic arthritis	0.000164	0.00198	CcSEcCtD
Mifepristone—Dermatitis—Prednisolone—psoriatic arthritis	0.000164	0.00198	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000164	0.00198	CcSEcCtD
Mifepristone—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000164	0.00198	CcSEcCtD
Mifepristone—Fatigue—Prednisone—psoriatic arthritis	0.000163	0.00197	CcSEcCtD
Mifepristone—Headache—Prednisolone—psoriatic arthritis	0.000163	0.00197	CcSEcCtD
Mifepristone—Discomfort—Methotrexate—psoriatic arthritis	0.000163	0.00197	CcSEcCtD
Mifepristone—Constipation—Prednisone—psoriatic arthritis	0.000162	0.00196	CcSEcCtD
Mifepristone—Dizziness—Triamcinolone—psoriatic arthritis	0.000159	0.00191	CcSEcCtD
Mifepristone—Dizziness—Methylprednisolone—psoriatic arthritis	0.000158	0.00191	CcSEcCtD
Mifepristone—Infection—Methotrexate—psoriatic arthritis	0.000157	0.0019	CcSEcCtD
Mifepristone—Feeling abnormal—Prednisone—psoriatic arthritis	0.000156	0.00188	CcSEcCtD
Mifepristone—Asthenia—Betamethasone—psoriatic arthritis	0.000156	0.00188	CcSEcCtD
Mifepristone—Asthenia—Dexamethasone—psoriatic arthritis	0.000156	0.00188	CcSEcCtD
Mifepristone—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000155	0.00187	CcSEcCtD
Mifepristone—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000155	0.00187	CcSEcCtD
Mifepristone—Nausea—Prednisolone—psoriatic arthritis	0.000155	0.00187	CcSEcCtD
Mifepristone—Pruritus—Dexamethasone—psoriatic arthritis	0.000154	0.00186	CcSEcCtD
Mifepristone—Pruritus—Betamethasone—psoriatic arthritis	0.000154	0.00186	CcSEcCtD
Mifepristone—Skin disorder—Methotrexate—psoriatic arthritis	0.000154	0.00186	CcSEcCtD
Mifepristone—Vomiting—Triamcinolone—psoriatic arthritis	0.000153	0.00184	CcSEcCtD
Mifepristone—Vomiting—Methylprednisolone—psoriatic arthritis	0.000152	0.00184	CcSEcCtD
Mifepristone—Rash—Triamcinolone—psoriatic arthritis	0.000151	0.00182	CcSEcCtD
Mifepristone—Dermatitis—Triamcinolone—psoriatic arthritis	0.000151	0.00182	CcSEcCtD
Mifepristone—Anorexia—Methotrexate—psoriatic arthritis	0.000151	0.00182	CcSEcCtD
Mifepristone—Rash—Methylprednisolone—psoriatic arthritis	0.000151	0.00182	CcSEcCtD
Mifepristone—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000151	0.00182	CcSEcCtD
Mifepristone—Urticaria—Prednisone—psoriatic arthritis	0.000151	0.00182	CcSEcCtD
Mifepristone—Headache—Triamcinolone—psoriatic arthritis	0.00015	0.00181	CcSEcCtD
Mifepristone—Headache—Methylprednisolone—psoriatic arthritis	0.00015	0.00181	CcSEcCtD
Mifepristone—Abdominal pain—Prednisone—psoriatic arthritis	0.00015	0.00181	CcSEcCtD
Mifepristone—Body temperature increased—Prednisone—psoriatic arthritis	0.00015	0.00181	CcSEcCtD
Mifepristone—Diarrhoea—Betamethasone—psoriatic arthritis	0.000149	0.0018	CcSEcCtD
Mifepristone—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000149	0.0018	CcSEcCtD
Mifepristone—Hypotension—Methotrexate—psoriatic arthritis	0.000148	0.00179	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000144	0.00174	CcSEcCtD
Mifepristone—Dizziness—Betamethasone—psoriatic arthritis	0.000144	0.00174	CcSEcCtD
Mifepristone—Dizziness—Dexamethasone—psoriatic arthritis	0.000144	0.00174	CcSEcCtD
Mifepristone—Insomnia—Methotrexate—psoriatic arthritis	0.000143	0.00173	CcSEcCtD
Mifepristone—Nausea—Triamcinolone—psoriatic arthritis	0.000142	0.00172	CcSEcCtD
Mifepristone—Nausea—Methylprednisolone—psoriatic arthritis	0.000142	0.00171	CcSEcCtD
Mifepristone—Dyspnoea—Methotrexate—psoriatic arthritis	0.000141	0.0017	CcSEcCtD
Mifepristone—Somnolence—Methotrexate—psoriatic arthritis	0.000141	0.0017	CcSEcCtD
Mifepristone—Hypersensitivity—Prednisone—psoriatic arthritis	0.00014	0.00168	CcSEcCtD
Mifepristone—Vomiting—Dexamethasone—psoriatic arthritis	0.000138	0.00167	CcSEcCtD
Mifepristone—Vomiting—Betamethasone—psoriatic arthritis	0.000138	0.00167	CcSEcCtD
Mifepristone—Decreased appetite—Methotrexate—psoriatic arthritis	0.000138	0.00166	CcSEcCtD
Mifepristone—Rash—Dexamethasone—psoriatic arthritis	0.000137	0.00166	CcSEcCtD
Mifepristone—Rash—Betamethasone—psoriatic arthritis	0.000137	0.00166	CcSEcCtD
Mifepristone—Dermatitis—Dexamethasone—psoriatic arthritis	0.000137	0.00165	CcSEcCtD
Mifepristone—Dermatitis—Betamethasone—psoriatic arthritis	0.000137	0.00165	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000137	0.00165	CcSEcCtD
Mifepristone—Fatigue—Methotrexate—psoriatic arthritis	0.000137	0.00165	CcSEcCtD
Mifepristone—Headache—Betamethasone—psoriatic arthritis	0.000136	0.00164	CcSEcCtD
Mifepristone—Headache—Dexamethasone—psoriatic arthritis	0.000136	0.00164	CcSEcCtD
Mifepristone—Asthenia—Prednisone—psoriatic arthritis	0.000136	0.00164	CcSEcCtD
Mifepristone—Pain—Methotrexate—psoriatic arthritis	0.000135	0.00163	CcSEcCtD
Mifepristone—Pruritus—Prednisone—psoriatic arthritis	0.000134	0.00162	CcSEcCtD
Mifepristone—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000131	0.00157	CcSEcCtD
Mifepristone—Diarrhoea—Prednisone—psoriatic arthritis	0.00013	0.00156	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00013	0.00156	CcSEcCtD
Mifepristone—Nausea—Betamethasone—psoriatic arthritis	0.000129	0.00156	CcSEcCtD
Mifepristone—Nausea—Dexamethasone—psoriatic arthritis	0.000129	0.00156	CcSEcCtD
Mifepristone—Urticaria—Methotrexate—psoriatic arthritis	0.000126	0.00152	CcSEcCtD
Mifepristone—Dizziness—Prednisone—psoriatic arthritis	0.000125	0.00151	CcSEcCtD
Mifepristone—Abdominal pain—Methotrexate—psoriatic arthritis	0.000125	0.00151	CcSEcCtD
Mifepristone—Body temperature increased—Methotrexate—psoriatic arthritis	0.000125	0.00151	CcSEcCtD
Mifepristone—Vomiting—Prednisone—psoriatic arthritis	0.000121	0.00145	CcSEcCtD
Mifepristone—Rash—Prednisone—psoriatic arthritis	0.00012	0.00144	CcSEcCtD
Mifepristone—Dermatitis—Prednisone—psoriatic arthritis	0.000119	0.00144	CcSEcCtD
Mifepristone—Headache—Prednisone—psoriatic arthritis	0.000119	0.00143	CcSEcCtD
Mifepristone—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000117	0.00141	CcSEcCtD
Mifepristone—Asthenia—Methotrexate—psoriatic arthritis	0.000114	0.00137	CcSEcCtD
Mifepristone—Nausea—Prednisone—psoriatic arthritis	0.000113	0.00136	CcSEcCtD
Mifepristone—Pruritus—Methotrexate—psoriatic arthritis	0.000112	0.00135	CcSEcCtD
Mifepristone—Diarrhoea—Methotrexate—psoriatic arthritis	0.000108	0.00131	CcSEcCtD
Mifepristone—Dizziness—Methotrexate—psoriatic arthritis	0.000105	0.00126	CcSEcCtD
Mifepristone—Vomiting—Methotrexate—psoriatic arthritis	0.000101	0.00121	CcSEcCtD
Mifepristone—Rash—Methotrexate—psoriatic arthritis	9.99e-05	0.0012	CcSEcCtD
Mifepristone—Dermatitis—Methotrexate—psoriatic arthritis	9.98e-05	0.0012	CcSEcCtD
Mifepristone—Headache—Methotrexate—psoriatic arthritis	9.92e-05	0.0012	CcSEcCtD
Mifepristone—Nausea—Methotrexate—psoriatic arthritis	9.41e-05	0.00113	CcSEcCtD
